A 62-year-old man with a 40-year smoking history presents with a 3-month history of progressive claudication in the left calf and foot. He reports pain after walking 200 metres that resolves with rest. On examination, the left femoral pulse is palpable but the popliteal and distal pulses are absent. The ankle-brachial index (ABI) on the left is 0.58. Duplex ultrasound shows a 90% stenosis of the left superficial femoral artery (SFA). The patient is on aspirin 75 mg daily and atorvastatin 40 mg daily. What is the most appropriate next step in management?

Explanation

## Clinical Assessment of Claudication Severity **Key Point:** This patient has intermittent claudication (Fontaine Stage II) with significant haemodynamic compromise (ABI 0.58). Management follows a stepwise approach based on symptom severity and functional impact. ### Fontaine Classification of PAD | Stage | Clinical Features | ABI Range | |-------|-------------------|----------| | I | Asymptomatic | < 0.9 | | II | Intermittent claudication | 0.4–0.9 | | III | Rest pain | 0.2–0.4 | | IV | Tissue loss (ulcer/gangrene) | < 0.2 | **High-Yield:** Claudication alone does NOT mandate intervention. First-line management is **conservative**: smoking cessation, supervised exercise, and optimised medical therapy (antiplatelet + statin). Intervention is reserved for: - Failure of conservative therapy (persistent symptoms limiting quality of life) - Lifestyle-limiting claudication unresponsive to 3–6 months of exercise - Critical limb ischaemia (rest pain, tissue loss) ### Why Conservative Management First? 1. **Natural history:** ~50% of claudicants improve or stabilise with exercise alone 2. **Symptom improvement:** Supervised exercise increases walking distance by 50–100% in 3 months 3. **Cardiovascular risk reduction:** Aggressive lipid and blood pressure control reduce MI/stroke risk more than revascularisation 4. **Durability:** PTA/stent patency rates are lower in SFA disease; reserve for failed conservative therapy **Clinical Pearl:** The SFA is the most common site of claudication in the lower limb. Although 90% stenosis is significant, the presence of collateral circulation (evidenced by palpable femoral pulse) means the limb is viable and claudication is the only symptom. ### Indications for Intervention in Claudication - Lifestyle-limiting symptoms despite 3–6 months supervised exercise - High-risk occupation (e.g. postman, manual labourer) - Anatomically favourable lesions (short, non-calcified SFA stenosis) - Patient preference after counselling on risks/benefits **Warning:** Immediate PTA/stenting in stable claudication increases cost, radiation exposure, and stent thrombosis risk without proven long-term benefit over conservative therapy. ### Optimised Medical Therapy - **Antiplatelet:** Aspirin 75 mg (already on board) - **Statin:** Atorvastatin 40 mg (adequate; no need to escalate for claudication alone) - **ACE inhibitor:** Consider if hypertensive or diabetic (cardioprotective) - **Cilostazol:** 100 mg BD can improve walking distance by ~50 m; consider if exercise plateau reached - **Smoking cessation:** Mandatory; improves prognosis dramatically **Mnemonic — SAFE PAD:** **S**moking cessation, **A**ntiplatelet, **F**itness (supervised exercise), **E**xercise; **P**ancreatic risk factors (lipids, BP, glucose), **A**ngiotensin inhibitor, **D**iabetes control.